The 60 mg vial easily accommodates this extended schedule
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH)
Anti-inflammatory effects often manifest first, typically within 1 to 3 days
Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, and Scott JM (1998)
The FDA approved selumetinib for the treatment of adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas
The water molecules mostly rearranged to form clathrate-like structures with the H-atoms of water molecules directed outward near the largely polar solvent accessible area of HFS, but water molecules in the vicinity of DFS likely prefer the H-atoms directed inward